Insider · CIK 0001716490

Versant Ventures V (Canada), L.P.

CIK 0001716490 Name as filed on the most recent filing

Filed as Versant Ventures V (Canada), L.P. (4)

12 transaction lines · from 4 filings · filed 2019-10-07 to 2023-07-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2023-07-25 Turnstone Biologics Corp.
TSBX
P, Open-market purchase 197,458 acquired 12.00 2,369,496.00 Form 4, filing 0001209191-23-043527
2023-07-25 Turnstone Biologics Corp.
TSBX
P, Open-market purchase 15,028 acquired 12.00 180,336.00 Form 4, filing 0001209191-23-043527
2023-07-25 Turnstone Biologics Corp.
TSBX
P, Open-market purchase 6,575 acquired 12.00 78,900.00 Form 4, filing 0001209191-23-043527
2023-07-25 Turnstone Biologics Corp.
TSBX
P, Open-market purchase 5,939 acquired 12.00 71,268.00 Form 4, filing 0001209191-23-043527
2022-06-03 Repare Therapeutics Inc.
RPTX
S, Open-market sale 438,795 disposed 12.25 5,375,984.70 Form 4, filing 0000899243-22-021348
2022-06-03 Repare Therapeutics Inc.
RPTX
S, Open-market sale 250,000 disposed 12.25 3,062,925.00 Form 4, filing 0000899243-22-021348
2022-06-03 Repare Therapeutics Inc.
RPTX
S, Open-market sale 33,395 disposed 12.25 409,145.52 Form 4, filing 0000899243-22-021348
2022-06-03 Repare Therapeutics Inc.
RPTX
S, Open-market sale 14,611 disposed 12.25 179,009.59 Form 4, filing 0000899243-22-021348
2022-06-03 Repare Therapeutics Inc.
RPTX
S, Open-market sale 13,199 disposed 12.25 161,710.19 Form 4, filing 0000899243-22-021348
2020-06-23 Repare Therapeutics Inc.
RPTX
P, Open-market purchase 150,000 acquired 20.00 3,000,000.00 Form 4, filing 0001209191-20-038990
2020-06-23 Repare Therapeutics Inc.
RPTX
P, Open-market purchase 100,000 acquired 20.00 2,000,000.00 Form 4, filing 0001209191-20-038990
2019-10-07 Aprea Therapeutics, Inc.
APRE
P, Open-market purchase 333,333 acquired 15.00 4,999,995.00 Form 4, filing 0001140361-19-018090

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Versant Ventures V (Canada), L.P., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001716490

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.